Walleye Capital
PPH icon

Walleye Capital’s VanEck Pharmaceutical ETF PPH Stock Holding History

Walleye Capital’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,127
Closed -$479K – 3543
2022
Q3 		$479K Buy
+7,127
New +$525K 0.01% 1505

Other funds holding PPH

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VAS
Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return

Walleye Capital's PPH Position: Q4 2022 in Review

Walleye Capital sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2022, closing a stake of 7,127 shares — an estimated $479K sold.

Walleye Capital first reported a position in PPH in Q3 2022 and held it in 1 quarter. The position peaked at $479K in Q3 2022. 114 funds tracked by Wall St. Rank hold PPH as of Q4 2022.

  • Walleye Capital reported no remaining VanEck Pharmaceutical ETF position as of Q4 2022 after selling out during the quarter.
  • Walleye Capital sold 7,127 VanEck Pharmaceutical ETF shares in Q4 2022, an estimated $479K.
  • Walleye Capital first reported a position in VanEck Pharmaceutical ETF in Q3 2022 and held it in 1 quarter.
  • Walleye Capital's VanEck Pharmaceutical ETF position peaked at $479K in Q3 2022.
  • 114 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.